Literature DB >> 24622884

Deregulation of base excision repair gene expression and enhanced proliferation in head and neck squamous cell carcinoma.

Ishrat Mahjabeen1, Kashif Ali, Xiaofeng Zhou, Mahmood Akhtar Kayani.   

Abstract

Defects in the DNA damage repair pathway contribute to cancer. The major pathway for oxidative DNA damage repair is base excision repair (BER). Although BER pathway genes (OGG1, APEX1 and XRCC1) have been investigated in a number of cancers, our knowledge on the prognostic significance of these genes and their role in head and neck squamous cell carcinoma is limited. Protein levels of OGG1, APEX1 and XRCC1 and a proliferation marker, Ki-67, were examined by immunohistochemical analysis, in a cohort of 50 HNSCC patients. Significant downregulation of OGG1 (p<0.04) and XRCC1 (p<0.05) was observed in poorly differentiated HNSCC compared to mod-well-differentiated cases. Significant upregulation of APEX1 (p<0.05) and Ki-67 (p<0.05) was observed in poorly differentiated HNSCC compared to mod-well-differentiated cases. Significant correlation was observed between XRCC1 and OGG1 (r=0.33, p<0.02). Inverse correlations were observed between OGG1 and Ki-67 (r=-0.377, p<0.005), between APEX1 and XRCC1 (r=-0.435, p<0.002) and between OGG1 and APEX1 (r=-0.34, p<0.02) in HNSCC. To confirm our observations, we examined BER pathway genes and a proliferation marker, Ki-67, expression at the mRNA level on 50 head and neck squamous cell carcinoma (HNSCC) and 50 normal control samples by quantitative real-time polymerase chain reaction. Significant downregulation was observed in case of OGG1 (p<0.04) and XRCC1 (p<0.02), while significant upregulation was observed in case of APEX1 (p<0.01) and Ki-67 (p<0.03) in HNSCC tissue samples compared to controls. Our data suggested that deregulation of base excision repair pathway genes, such as OGG1, APEX1 and XRCC1, combined with overexpression of Ki-67, a marker for excessive proliferation, may contribute to progression of HNSCC in Pakistani population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24622884     DOI: 10.1007/s13277-014-1792-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  67 in total

Review 1.  The base excision repair: mechanisms and its relevance for cancer susceptibility.

Authors:  P Fortini; B Pascucci; E Parlanti; M D'Errico; V Simonelli; E Dogliotti
Journal:  Biochimie       Date:  2003-11       Impact factor: 4.079

2.  Expression pattern of apurinic/apyrimidinic endonuclease in sinonasal squamous cell carcinoma.

Authors:  Jin Woo Lee; Jun Jin; Ki-Sang Rha; Yong Min Kim
Journal:  Otolaryngol Head Neck Surg       Date:  2012-05-29       Impact factor: 3.497

3.  Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor.

Authors:  Sun Yang; Kaikobad Irani; Susan E Heffron; Frances Jurnak; Frank L Meyskens
Journal:  Mol Cancer Ther       Date:  2005-12       Impact factor: 6.261

4.  Base excision repair of reactive oxygen species-initiated 7,8-dihydro-8-oxo-2'-deoxyguanosine inhibits the cytotoxicity of platinum anticancer drugs.

Authors:  Thomas J Preston; Jeffrey T Henderson; Gordon P McCallum; Peter G Wells
Journal:  Mol Cancer Ther       Date:  2009-06-30       Impact factor: 6.261

5.  Transcriptional activation of apurinic/apyrimidinic endonuclease (Ape, Ref-1) by oxidative stress requires CREB.

Authors:  S Grösch; B Kaina
Journal:  Biochem Biophys Res Commun       Date:  1999-08-11       Impact factor: 3.575

6.  XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions.

Authors:  A E Vidal; S Boiteux; I D Hickson; J P Radicella
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

7.  The prognostic significance of ERCC1, BRCA1, XRCC1, and betaIII-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection.

Authors:  Chang Hyun Kang; Bo Gun Jang; Dong-Wan Kim; Doo Hyun Chung; Young Tae Kim; Sanghoon Jheon; Sook-Whan Sung; Joo Hyun Kim
Journal:  Lung Cancer       Date:  2009-08-15       Impact factor: 5.705

8.  Studies of apurinic/apyrimidinic endonuclease/ref-1 expression in epithelial ovarian cancer: correlations with tumor progression and platinum resistance.

Authors:  Sarah Freitas; David H Moore; Helen Michael; Mark R Kelley
Journal:  Clin Cancer Res       Date:  2003-10-15       Impact factor: 12.531

9.  Absence of the DNA repair enzyme human 8-oxoguanine glycosylase is associated with an aggressive breast cancer phenotype.

Authors:  P Karihtala; S Kauppila; U Puistola; A Jukkola-Vuorinen
Journal:  Br J Cancer       Date:  2011-11-22       Impact factor: 7.640

10.  Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers.

Authors:  A Al-Attar; L Gossage; K R Fareed; M Shehata; M Mohammed; A M Zaitoun; I Soomro; D N Lobo; R Abbotts; S Chan; S Madhusudan
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

View more
  11 in total

1.  Potent and Selective Inhibitors of 8-Oxoguanine DNA Glycosylase.

Authors:  Yu-Ki Tahara; Douglas Auld; Debin Ji; Andrew A Beharry; Anna M Kietrys; David L Wilson; Marta Jimenez; Daniel King; Zachary Nguyen; Eric T Kool
Journal:  J Am Chem Soc       Date:  2018-02-05       Impact factor: 15.419

2.  Association of intronic polymorphisms (rs1549339, rs13402242) and mRNA expression variations in PSMD1 gene in arsenic-exposed workers.

Authors:  Saqiba Ahmad; Bushra Arif; Zertashia Akram; Malik Waqar Ahmed; Asad Ullah Khan; Muhammad Zahid Hussain; Faisal Rahman; Mahmood Akhtar Kayani; Ishrat Mahjabeen
Journal:  Environ Sci Pollut Res Int       Date:  2020-01-21       Impact factor: 4.223

3.  Apurinic/apyrimidinic endonuclease 1 (APE1) is overexpressed in malignant transformation of salivary gland pleomorphic adenoma.

Authors:  Leorik Pereira Silva; Thalita Santana; Bruno Tavares Sedassari; Suzana Machado de Sousa; Ana Paula Veras Sobral; Roseana de Almeida Freitas; Carlos Augusto Galvão Barboza; Lélia Batista de Souza
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-05-18       Impact factor: 2.503

4.  Dual Inhibitors of 8-Oxoguanine Surveillance by OGG1 and NUDT1.

Authors:  Yu-Ki Tahara; Anna M Kietrys; Marian Hebenbrock; Yujeong Lee; David L Wilson; Eric T Kool
Journal:  ACS Chem Biol       Date:  2019-10-29       Impact factor: 5.100

Review 5.  Exploiting DNA Endonucleases to Advance Mechanisms of DNA Repair.

Authors:  Marlo K Thompson; Robert W Sobol; Aishwarya Prakash
Journal:  Biology (Basel)       Date:  2021-06-14

6.  Loss of Mitochondrial Tumor Suppressor Genes Expression Is Associated with Unfavorable Clinical Outcome in Head and Neck Squamous Cell Carcinoma: Data from Retrospective Study.

Authors:  Ishrat Mahjabeen; Mahmood Akhtar Kayani
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

7.  Misregulation of DNA damage repair pathways in HPV-positive head and neck squamous cell carcinoma contributes to cellular radiosensitivity.

Authors:  Catherine M Nickson; Parisa Moori; Rachel J Carter; Carlos P Rubbi; Jason L Parsons
Journal:  Oncotarget       Date:  2017-05-02

8.  Significant Association Between XRCC1 Expression and Its rs25487 Polymorphism and Radiotherapy-Related Cancer Prognosis.

Authors:  Li Gong; Ming Luo; Renhuang Sun; Li Qiu; Chunli Chen; Zhiguo Luo
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244

9.  Bu-Fei decoction and modified Bu-Fei decoction inhibit the growth of non-small cell lung cancer, possibly via inhibition of apurinic/apyrimidinic endonuclease 1.

Authors:  Shan-Tong Jiang; Shu-Yan Han; Li-Na Pang; Yan-Na Jiao; Xi-Ran He; Ping-Ping Li
Journal:  Int J Mol Med       Date:  2018-01-30       Impact factor: 4.101

10.  Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone.

Authors:  Gaurab Chakrabarti; Molly A Silvers; Mariya Ilcheva; Yuliang Liu; Zachary R Moore; Xiuquan Luo; Jinming Gao; Glenda Anderson; Lili Liu; Venetia Sarode; David E Gerber; Sandeep Burma; Ralph J DeBerardinis; Stanton L Gerson; David A Boothman
Journal:  Sci Rep       Date:  2015-11-25       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.